台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    38.80
  • 漲跌
    ▲0.70
  • 漲幅
    +1.84%
  • 成交量
    161
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-元大-屏東民生 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0104/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/203537.54042.54547.550May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元大-屏東民生 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/31338.1000.0038.1031611.85%
2025/03/28339.7300.0039.6031571.90%
2025/03/2400.002242.0341.80-22149-14.73%
2025/03/20042.7500.0042.6501490.00%
2025/03/13643.3200.0042.6061484.04%
2025/03/07144.1000.0044.2511480.68%
2025/03/03245.1300.0044.6021531.31%
2025/02/26145.5000.0045.8011500.66%
2025/02/25145.4000.0045.6011530.65%
2025/02/20044.6500.0045.2501480.00%
2025/02/1100.00643.5443.75-6176-3.41%
2025/01/20241.4000.0041.6523780.53%
2025/01/09543.0500.0043.9553861.29%
2024/12/27245.8000.0044.2524210.47%
2024/12/13242.3500.0042.3525870.34%
2024/12/02245.25145.2545.4016340.16%
2024/11/28444.2000.0044.4546450.62%
2024/11/22646.4300.0045.3566690.90%
2024/11/18444.00145.3044.1036990.43%
2024/11/15246.4000.0046.2526960.29%
2024/11/12147.5500.0047.3517260.14%
2024/11/08548.9700.0048.6057350.68%
2024/11/07150.1000.0049.4517420.13%
2024/11/05249.5000.0049.6027550.26%
2024/11/04949.7500.0049.7097741.16%
2024/11/01649.7000.0050.0067780.77%
2024/10/30151.0000.0050.5017770.13%
2024/10/29752.4100.0052.1077720.91%
2024/10/281055.51456.7052.6067560.79%
2024/10/25354.27252.3054.4016450.15%
2024/10/24350.0000.0049.5036230.48%
2024/10/23249.6000.0050.0026280.32%
2024/10/22349.7200.0049.6036460.46%
2024/10/21350.0000.0049.9036600.45%
2024/10/09649.3000.0049.1561,0590.57%
2024/10/04152.3000.0052.4011,0520.10%
2024/09/26152.90251.8051.90-11,023-0.10%
2024/09/23254.9000.0054.6021,0190.20%
2024/09/20155.00154.9055.0001,0230.00%
2024/09/09248.25248.4348.2001,0340.00%
2024/07/31156.0000.0056.5017990.13%
2024/07/29156.40156.8056.9007880.00%
2024/07/1900.00259.3058.10-2735-0.27%
2024/07/18163.200.362.5062.200.76580.11%
2024/07/17756.065.358.5258.901.85430.32%
2024/07/1600.00457.0557.20-4427-0.94%
2024/07/0500.00545.0545.65-5312-1.60%
2024/06/26248.80148.8048.7512880.35%
2024/06/20848.78747.6847.6012500.40%
2024/06/19544.69544.4147.9502240.00%
2024/06/1800.00244.7544.00-2213-0.94%
2024/06/17245.3000.0045.3521871.07%
2024/06/1200.00341.8741.80-3152-1.97%
2024/04/1600.00141.3041.25-1184-0.54%
2024/04/08144.6000.0044.2011910.52%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音
 
 
55小時7